CEP192 and breast cancer: Moreover, topographic single cell sequencing comparison between in situ versus invasive ductal carcinoma breast cancers revealed that CEP192 is one of eleven misregulated genes of an invasive signature from a specific mutation47, further supporting the role of this module in cancer migration and invasion.